By Professor Monica M. Lahra

Journal articles

George CR; Booy R; Nissen MD; Lahra MM, 2022, 'The decline of invasive meningococcal disease and influenza in the time of COVID-19: the silver linings of the pandemic playbook', Medical Journal of Australia, 216, pp. 504 - 507, http://dx.doi.org/10.5694/mja2.51463

Lahra MM; Shoushtari M; Hogan TR, 2022, 'Meningococcal Surveillance Australia Reporting period 1 October to 31 December 2021', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.21

Hui BB; Padeniya TN; Rebuli N; Gray RT; Wood JG; Donovan B; Duan Q; Guy R; Hocking JS; Lahra MM; Lewis DA; Whiley DM; Regan DG; Seib KL, 2022, 'A Gonococcal Vaccine Has the Potential to Rapidly Reduce the Incidence of Neisseria gonorrhoeae Infection among Urban Men Who Have Sex with Men', Journal of Infectious Diseases, 225, pp. 983 - 993, http://dx.doi.org/10.1093/infdis/jiab581

Lahra MM; Shoushtari M; Hogan TR, 2022, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2021', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.1

Cabrera-Aguas M; Khoo P; George CRR; Lahra MM; Watson SL, 2022, 'Predisposing factors, microbiological features and outcomes of patients with clinical presumed concomitant microbial and herpes simplex keratitis', Eye (Basingstoke), 36, pp. 86 - 94, http://dx.doi.org/10.1038/s41433-021-01440-1

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Australian Gonococcal Surveillance Programme 1 April to 30 June 2021', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.68

Lahra MM; Shoushtari M; Hogan T, 2021, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2021', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.63

Duan Q; Carmody C; Donovan B; Guy RJ; Hui BB; Kaldor JM; Lahra MM; Law MG; Lewis DA; Maley M; McGregor S; McNulty A; Selvey C; Templeton DJ; Whiley DM; Regan DG; Wood JG, 2021, 'Modelling response strategies for controlling gonorrhoea outbreaks in men who have sex with men in Australia', PLoS Computational Biology, 17, pp. e1009385, http://dx.doi.org/10.1371/journal.pcbi.1009385

Unemo M; Lahra MM; Escher M; Eremin S; Cole MJ; Galarza P; Ndowa F; Martin I; Dillon JAR; Galas M; Ramon-Pardo P; Weinstock H; Wi T, 2021, 'WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18: a retrospective observational study', The Lancet Microbe, 2, pp. e627 - e636, http://dx.doi.org/10.1016/S2666-5247(21)00171-3

Lahra MM; Hogan TR; Shoushtari M; Armstrong BH, 2021, 'Australian Gonococcal Surveillance Programme Annual Report, 2020', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.58

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Australian Gonococcal Surveillance Programme 1 October to 31 December 2020', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.44

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2021', Communicable diseases intelligence (2018), 45

Lahra MM; George CRR; Shoushtari M; Hogan TR, 2021, 'Australian Meningococcal Surveillance Programme Annual Report, 2020', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.46

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Communicable Diseases Intelligence', COMMUNICABLE DISEASES INTELLIGENCE, 45, http://dx.doi.org/10.33321/cdi.2021.45.47

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2021', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.45

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2020', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.36

Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR, 2021, 'Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18', Journal of Antimicrobial Chemotherapy, 76, pp. 1815 - 1821, http://dx.doi.org/10.1093/jac/dkab099

Lahra MM; Hogan TR; Shoushtari M; Armstrong BH, 2021, 'Australian Gonococcal Surveillance Programme Annual Report, 2020', COMMUNICABLE DISEASES INTELLIGENCE, 45, http://dx.doi.org/10.33321/cdi.2021.45.24

Lahra MM; Hogan TR; Shoushtari M; Armstrong BH, 2021, 'Australian Gonococcal Surveillance Programme Annual Report, 2020', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.24

Armstrong BH; Limnios A; Lewis DA; Hogan T; Kundu R; Ray S; Shoushtari M; El Nasser J; Driscoll T; Lahra MM, 2021, 'Is gentamicin a viable therapeutic option for treating resistant Neisseria gonorrhoeae in New South Wales?', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.12

Trembizki E; Jennison AV; Buckley C; Bright A; Holds J; Ward A; Pitt J; Pendle S; Baird R; Freeman K; Robson J; Mhango L; Lowry K; Lahra M; Whiley D, 2021, 'Enhanced molecular surveillance in response to the detection of extensively resistant gonorrhoea in Australia', Journal of Antimicrobial Chemotherapy, 76, pp. 270 - 271, http://dx.doi.org/10.1093/JAC/DKAA402

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme 1 July to 30 September 2020', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.96

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Meningococcal Surveillance Australia Reporting period 1 July to 30 September 2020', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.95

Hong S; Putsathit P; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR, 2020, 'Laboratory-based surveillance of clostridium difficile infection in australian health care and community settings, 2013 to 2018', Journal of Clinical Microbiology, 58, http://dx.doi.org/10.1128/JCM.01552-20

Cabrera-Aguas M; Khoo P; Lahra MM; Watson SL, 2020, 'Travel associated microbial keratitis: is resistance a risk?', Travel Medicine and Infectious Disease, 38, http://dx.doi.org/10.1016/j.tmaid.2020.101903

Watson SL; Gatus BJ; Cabrera-Aguas M; Armstrong BH; George CR; Khoo P; Lahra MM, 2020, 'Bacterial Ocular Surveillance System (BOSS) Sydney, Australia 2017-2018', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.86

Lahra MM; Shoushtari M; Ray S, 2020, 'Meningococcal Surveillance Australia Reporting period 1 April to 30 June 2020', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.81

Hepschke JL; Ung L; Cabrera-Aguas M; Ross C; Kumar N; Lahra MM; Watson S, 2020, 'Pediatric Microbial Keratitis: Experience From Tertiary Referral Centers in New South Wales, Australia', Pediatric Infectious Disease Journal, 39, pp. 883 - 888, http://dx.doi.org/10.1097/INF.0000000000002723

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme: 1 April to 30 June 2020', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.74

Lahra MM; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme: 1 July to 30 September 2019', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.73

Ferreyra C; Osborn J; Moussy F; Alirol E; Lahra M; Whiley D; Shafer W; Unemo M; Klausner J; Cirino CK; Wi T, 2020, 'Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensus', PLoS ONE, 15, http://dx.doi.org/10.1371/journal.pone.0237424

Lahra MM; Hogan TR, 2020, 'Australian Meningococcal Surveillance Programme annual report, 2019', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.62

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Meningococcal Surveillance Australia Reporting period 1 January to 31 March 2020', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.65

George CRR; Kundu RL; Whiley DM; Lahra MM, 2020, 'Are sex norms the norm in gonococcal surveillance?', The Lancet Microbe, 1, pp. e143 - e144, http://dx.doi.org/10.1016/S2666-5247(20)30087-2

Khoo P; Cabrera-Aguas MP; Nguyen V; Lahra MM; Watson SL, 2020, 'Microbial keratitis in Sydney, Australia: risk factors, patient outcomes, and seasonal variation', Graefe's Archive for Clinical and Experimental Ophthalmology, 258, pp. 1745 - 1755, http://dx.doi.org/10.1007/s00417-020-04681-0

Lahra MM; Shoushtari M; George CRR; Armstrong BH; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme Annual Report, 2019', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.58

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2020', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.61

Lahra MM; Hogan TR, 2020, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2019', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.47

Lahra MM; Hogan TR, 2020, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2019', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.50

Lahra MM; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2019', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.37

Lahra MM; Enriquez RP; Hogan TP, 2020, 'Australian Meningococcal Surveillance Programme annual report, 2018', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.10

Cabrera-Aguas M; Khoo P; George CRR; Lahra MM; Watson SL, 2020, 'Antimicrobial resistance trends in bacterial keratitis over 5 years in Sydney, Australia', Clinical and Experimental Ophthalmology, 48, pp. 183 - 191, http://dx.doi.org/10.1111/ceo.13672

Fifer H; Hughes G; Whiley D; Lahra MM, 2020, 'Lessons learnt from ceftriaxone-resistant gonorrhoea in the UK and Australia', The Lancet Infectious Diseases, 20, pp. 276 - 278, http://dx.doi.org/10.1016/S1473-3099(20)30055-4

Lahra MM; Enriquez RP; George CRR, 2020, 'Australian Gonococcal Surveillance Programme 1 April to 30 June 2018', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.5

Lahra MM; Enriquez RP, 2020, 'Australian Gonococcal Surveillance Programme 1 January to 31 March 2019', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.3

Lahra MM; Enriquez RP; George CRR, 2020, 'Australian Gonococcal Surveillance Programme Annual Report, 2018', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.4

Lahra MM; Enriquez RP, 2020, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2019', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.9

Gilbey T; McIver C; Brandenburg U; Goeman E; Polkinghorne A; Lahra M; Branley J, 2020, 'Suspected materno-fetal transmission of neisseria meningitidis serogroup w clonal complex 11 causing early- onset neonatal sepsis', Open Forum Infectious Diseases, 7, http://dx.doi.org/10.1093/ofid/ofaa039

Lahra MM; Enriquez RP, 2020, 'Australian Gonococcal Surveillance Programme 1 April to 30 June 2017', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2019.44.7

Lahra MM; Enriquez RP, 2020, 'Australian Gonococcal Surveillance Programme 1 January to 31 March 2017', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2019.44.8

Back to profile page